6 months Fin 1mg, Min 5%, Microneedling weekly
    Progress Pictures 7/9/2024

    From the encyclopedia
    Finasteride β†’

    Frontline, gold standard treatment for combatting androgenic alopecia

    Minoxidil β†’

    An essential vasodilator with some anti-androgenic effects

    Microneedling β†’

    technique to create small wounds in skin to activate collagen production and hair growth

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    πŸ’Š Finasteride (oral) 1mg 1x daily 6 months
    πŸ’§ Minoxidil (topical) 5% 1-2x daily 6 months
    β€’ Microneedling (null) null 1x weekly 6 months
    the tone is πŸ˜€ positive with some growth results.

    Other terms

    User is happy with 6 months of using finasteride 1mg, minoxidil 5%, and weekly microneedling, with no side effects. The post includes progress pictures.
    View this post in the Community β†’

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results
      Androgenetic Alopecia: An Update

      research Androgenetic alopecia: An update

      July 2023 in “JAAD International”
      This study describes androgenetic alopecia as a common non-scarring hair loss condition primarily influenced by genetic factors and androgen sensitivity, notably impacting psychosocial well-being, especially in females and younger males seeking treatment.

      research Platelet-rich plasma in androgenetic alopecia

      1 citations , January 2021 in “Indian Dermatology Online Journal”
      This expert group provided recommendations for preparing and using platelet-rich plasma in treating androgenetic alopecia, suggesting a manual double-spin method and specific dosing, although further studies on injectable platelet-rich fibrin are needed.

      research Female pattern hair lossβ€”An update

      12 citations , January 2020 in “Indian Dermatology Online Journal”
      This article discusses the causes, diagnosis, and treatment options for female pattern hair loss, emphasizing the role of topical minoxidil as a primary treatment, but provides no new clinical results.